The University of Chicago Header Logo

Connection

Girish Venkataraman to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Girish Venkataraman has written about Protein Kinase Inhibitors.
Girish Venkataraman
Connection Strength
0.062
Protein Kinase Inhibitors
  1. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.
    View in: PubMed
    Score: 0.036
  2. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget. 2016 Oct 18; 7(42):68833-68841.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.